Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Sayre Therapeutics logo — End-to-end solutions in Oncology & Immunology.

Sayre Therapeutics

End-to-end solutions in Oncology & Immunology.

Founded 2015 India India 29 employees Series Unknown Total: $9.00M Biotechnology, Health Care +2

General Information

Company Name Sayre Therapeutics
Founded Year 2015
Location India India +1
Founders / Decision Makers
Team member
Employees 29
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series Unknown
Social

Get notified when Sayre Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Sayre Therapeutics

Sayre Therapeutics is a biotechnology startup founded in 2015 and headquartered in India. The company's slogan highlights its focus on "End-to-end solutions in Oncology & Immunology." Sayre Therapeutics distinguishes itself by providing novel medicines, drug-delivery devices, companion diagnostics, and diagnostic imaging agents to various medical professionals, including medical oncologists, surgical oncologists, radiation oncologists, interventional radiologists, and rheumatologists. Their offerings encompass small molecules, recombinant proteins, monoclonal antibodies (mAbs), drug-delivery devices, and diagnostics in Oncology and Immunology. In September 2017, the company secured a $1.00M Debt Financing investment from InnoVen Capital. Sayre Therapeutics' business model covers Global access/early access programs, Named Patient programs, and securing product registrations for exclusive commercial distribution in South Asia. Overall, Sayre Therapeutics appears to be a promising player in the biotechnology industry, particularly in the field of Oncology and Immunology. With their comprehensive solutions and recent investment backing, the company is poised for potential growth and innovation in the medical field.

Taxonomy: Oncology, Immunology, Novel Drugs, Drug-delivery Devices, Companion Diagnostics, Diagnostic Imaging Agents, Recombinant Proteins, Monoclonal Antibodies, Global Access Programs, Named Patient Programs, Product Registrations, Exclusive Commercial Distribution, Molecular Diagnostics, Interventional Oncology, Neuro-Oncology

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• 1
Investor
04 Sep 2017
Venture Round •••••• 1
Investor
04 Sep 2017

Sayre Therapeutics Alternatives & Competitors

Sayre Therapeutics vs
Xcoo
Xcoo Japan

Genomic Intelligence Based on Advanced Computing, Chrovis

14 employees
Sayre Therapeutics vs
Tennessee Oncology
Tennessee Oncology United States

Caring for Cancer Patients is a Privilege!

Debt Financing
784 employees
Health Care
Compare Sayre Therapeutics vs Tennessee Oncology
Sayre Therapeutics vs
Noble Medical, Inc.
Noble Medical, Inc. United States

Results You Can Trust

19 employees
Also compare with: Sayre Therapeutics vs Generex Biotechnology Corporation Generex Biotechnology Corporation Sayre Therapeutics vs GenesisCare GenesisCare

FAQ About Sayre Therapeutics

End-to-end solutions in Oncology & Immunology.
Sayre Therapeutics was founded in 2015.
Sayre Therapeutics is headquartered in India.
Sayre Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness, Medical Devices.
Sayre Therapeutics has approximately 29 employees.
Sayre Therapeutics has completed 2 funding rounds, raising a total of $9.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Sayre Therapeutics include Xcoo, Tennessee Oncology, Noble Medical, Inc., PharmaMar, Generex Biotechnology Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sayre Therapeutics and Xcoo are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Sayre Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy